DOI 10.3760/cma.j.cn112137-20250919-02441
[Guidelines for the clinical management of patients with moyamoya disease and moyamoya syndrome(2025 edition)].
Аннотация
Moyamoya disease shows a notably higher prevalence in East Asian populations, particularly in Japan, Korea, and China, compared to Western countries. Recent epidemiological data from several provinces in China indicate that its incidence and prevalence continue to rise. Moyamoya disease can lead to both ischemic and hemorrhagic strokes, posing significant challenges to patients' long-term prognosis and to the public health system. The pathogenesis of moyamoya disease involves genetic, immune, and environmental factors; however, the exact mechanisms remain unclear. The indications and timing for diagnostic modalities and therapeutic interventions are still debated, highlighting the urgent need for evidence-based clinical management guidelines. Based on the characteristics of the Chinese population and the latest international research, this guideline provides comprehensive and systematic recommendations on epidemiology and population screening, clinical presentation and diagnosis, therapeutic strategies and selection, postoperative prognosis evaluation and follow-up, as well as the individualized management of special populations with moyamoya disease. A total of 35 recommendations are proposed, aiming to offer practical guidance for physicians and other healthcare professionals, further standardize diagnostic and therapeutic processes, improve the quality of care, and lay the foundation for future research. The main features of the recommendations in this guideline are as follows: (1) systematically reviewing domestic and international evidence and integrating it with clinical practice in China; (2) proposing a diagnosis and treatment process for Moyamoya disease that is suitable for the national context; (3) clarifying strategies for suspected diagnosis, confirmed diagnosis, differential diagnosis, and disease assessment; (4) emphasizing multi-modal comprehensive treatment including surgery, interventional procedures, and medication; (5) focusing on full-process follow-up management including prevention, screening, risk assessment, diagnosis and treatment, and rehabilitation; (6) highlighting multidisciplinary team collaboration and shared decision-making between doctors and patients.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.